Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. More Details
Flawless balance sheet with proven track record.
Share Price & News
How has Semler Scientific's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SMLR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SMLR's weekly volatility (6%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: SMLR exceeded the US Medical Equipment industry which returned 34.6% over the past year.
Return vs Market: SMLR exceeded the US Market which returned 33.8% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Semler Scientific's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Semler Scientific undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SMLR ($108.72) is trading below our estimate of fair value ($139)
Significantly Below Fair Value: SMLR is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SMLR is good value based on its PE Ratio (33.6x) compared to the US Medical Equipment industry average (53.4x).
PE vs Market: SMLR is poor value based on its PE Ratio (33.6x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: SMLR is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: SMLR is overvalued based on its PB Ratio (18.4x) compared to the US Medical Equipment industry average (4.8x).
How is Semler Scientific forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMLR's forecast earnings growth (12.4% per year) is above the savings rate (2%).
Earnings vs Market: SMLR's earnings (12.4% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: SMLR's earnings are forecast to grow, but not significantly.
Revenue vs Market: SMLR's revenue (23.9% per year) is forecast to grow faster than the US market (9.8% per year).
High Growth Revenue: SMLR's revenue (23.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SMLR's Return on Equity is forecast to be high in 3 years time
How has Semler Scientific performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SMLR has a high level of non-cash earnings.
Growing Profit Margin: SMLR's current net profit margins (43.4%) are higher than last year (42.4%).
Past Earnings Growth Analysis
Earnings Trend: SMLR has become profitable over the past 5 years, growing earnings by 65.8% per year.
Accelerating Growth: SMLR's earnings growth over the past year (52%) is below its 5-year average (65.8% per year).
Earnings vs Industry: SMLR earnings growth over the past year (52%) exceeded the Medical Equipment industry 40.5%.
Return on Equity
High ROE: SMLR's Return on Equity (54.8%) is considered outstanding.
How is Semler Scientific's financial position?
Financial Position Analysis
Short Term Liabilities: SMLR's short term assets ($40.7M) exceed its short term liabilities ($5.9M).
Long Term Liabilities: SMLR's short term assets ($40.7M) exceed its long term liabilities ($286.0K).
Debt to Equity History and Analysis
Debt Level: SMLR is debt free.
Reducing Debt: SMLR currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: SMLR has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SMLR has no debt, therefore coverage of interest payments is not a concern.
What is Semler Scientific current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SMLR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SMLR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SMLR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SMLR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SMLR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Doug Murphy-Chutorian (67 yo)
Dr. Douglas Murphy-Chutorian, also known as Doug, M.D. has been the Chief Executive Officer of Semler Scientific, Inc since October 31, 2012 and served as its President. Dr. Murphy-Chutorian serves as Corp...
CEO Compensation Analysis
Compensation vs Market: Doug's total compensation ($USD721.98K) is below average for companies of similar size in the US market ($USD2.33M).
Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.
Experienced Management: SMLR's management team is seasoned and experienced (8.7 years average tenure).
Experienced Board: SMLR's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.
Semler Scientific, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Semler Scientific, Inc.
- Ticker: SMLR
- Exchange: OTCPK
- Founded: 2007
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$734.293m
- Shares outstanding: 6.75m
- Website: https://www.semlerscientific.com
Number of Employees
- Semler Scientific, Inc.
- 911 Bern Court
- Suite 110
- San Jose
- United States
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company’s pr...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 22:11|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.